PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS

The National Institutes of Health, National Institute on Drug Abuse (NIDA) issued solicitation 75N95024R00003 to support its Drug Supply Program. The primary objective is to acquire, develop, analyze, store, and distribute authentic controlled and uncontrolled drug compounds, dosage forms, and research cigarettes to the addiction research community. The contractor will manage an inventory that includes marijuana and nicotine research cigarettes, morphine, methadone, naltrexone pellets, and various cannabinoid preparations such as cannabidiol and delta-9-tetrahydrocannabinol.

Contractual duties involve manufacturing drug dosage forms, importing compounds from international sources, and conducting frequent purity analyses under Drug Enforcement Administration regulations. This requirement is classified under NAICS 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and PSC AN11, HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. Work will be performed in the USA and authorized through the issuance of task orders to aid NIDA in promoting research on drug abuse and addiction.

The response deadline for this solicitation is November 15, 2024. Documentation for this opportunity includes the original solicitation and two amendments issued in October 2024. Scott Duernberger is the designated point of contact for this requirement, which was originally published on October 1, 2024, and last updated on October 28, 2024.